News and Media

Scientists at Yale School of Medicine think so, and an initiative funded by the Carol and Gene Ludwig Family Foundation is supporting efforts to find out more about how inflammation and immune responses contribute to neurodegenerative diseases.

In a new Yale study, published in JAMA Network Open, researchers examined the differences in active and disabled life expectancy among older people who experience illness and injury.

Carolyn Fredericks, MD, assistant professor of neurology at Yale School of Medicine and neurologist at Yale New Haven Hospital shares her expertise about healthy strategies that could help reduce risk of dementia later in life.

As the world’s population rapidly ages, a new study led by researchers at the Yale School of Public Health finds that people living with dementia are struggling at an alarming rate.

In an interview, Yale neurologist Benjamin Tolchin discusses a new consensus statement he co-authored on seizures, driver licensure, and medical reporting.

Yale researchers take a deep dive into studies about hearing, nanowire assembly, heart imaging, photosynthesis, Tourette disorder, and AI in scientific writing.

Congratulations to the following Yale Department of Internal Medicine faculty members who were recently promoted, appointed, or reappointed.

Restless Legs Syndrome (RLS) is a sleep and movement disorder that has been treated with dopamine agonists for nearly twenty years. The American Academy of Sleep Medicine (AASM) has issued new guidelines for treating this condition. Brian Koo, MD, associate professor of neurology and director of the Yale Center for Restless Legs Syndrome, played a role in developing the new guidelines and breaks down what patients should know.

The National Institute of Mental Health (NIMH) has awarded a five-year R01 grant to Serena Spudich, MD, MA, Gilbert H. Glaser Professor of Neurology; Todd Constable, PhD, Elizabeth Mears and House Jameson Professor of Radiology; and Lindsay McAlpine, MD, assistant professor of neurology for research that will employ the use of novel neuroimaging to understand the brain changes that occur alongside the neurologic symptoms of Long COVID.